Join ▶️ Latest Therapies on NAFLD Session

Hi Renukaprasad A R, Non-alcoholic fatty liver disease (NAFLD), the most prevalent chronic liver disease, is characterized by extremely complex pathogenetic mechanisms and multifactorial etiology. Novel therapeutics targeting the relationship between the microbiome, liver metabolism, response to inflammation, and the systemic consequences of metabolic syndrome are the way ahead. To get answers to all your queries related to the latest therapies for NAFLD, join us for an exclusive session with Dr. Pallavi Garg, TODAY, 3:00 PM IST onwards. Session highlights: Latest NAFLD research   Strategies to overcome the health burden of liver diseases New therapeutic targets Join Now   India's Largest Online Community Of Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*